We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bone Marrow Concentrate in the Treatment of Aneurysmal Bone Cysts: A Case Series Study.
- Authors
Andreani, Lorenzo; Shytaj, Sheila; Neri, Elisabetta; Cosseddu, Fabio; D'Arienzo, Antonio; Capanna, Rodolfo
- Abstract
Introduction. A recent attractive option regarding mesenchymal stem cells (MSC) application is the treatment of bone cystic lesions and in particular aneurysmal bone cysts (ABC), in order to stimulate intrinsic healing. We performed a retrospective evaluation of the results obtained at our institution. Methods. The study group consisted of 46 cases with an average follow-up of 33 months. Forty-two patients underwent percutaneous treatment as the first approach; four patients had curettage as first treatment. In all cases, autologous bone marrow concentrate (BMC) was associated too. The healing status was followed up through a plain radiograph 45 days and 2 months after the procedure. Results and Conclusions. At the final follow-up, thirty-six patients healed with a Neer type II aspect, nine healed with a type I aspect, and one patient was not classified having total hip arthroplasty. Bone marrow concentrate is easy to obtain and to manipulate and can be immediately available in a clinical setting. We can assert that the use of BMC must be encouraged being harmless and having an unquestionable high osteogenic and healing potential in bone defects.
- Subjects
ANEURYSMAL bone cyst; BONE marrow; TOTAL hip replacement; MESENCHYMAL stem cells; BONES; BONE regeneration; EOSINOPHILIC granuloma
- Publication
Stem Cells International, 2020, p1
- ISSN
1687-966X
- Publication type
Article
- DOI
10.1155/2020/8898145